Corey Ritter
ARCH Venture Partners
Corey Ritter
ARCH Venture Partners
Greater Chicago Area
Overview
Work Experience
Principal
2017 - Current
ARCH creates and invests in companies commercializing disruptive new technology developed by leading scientific researchers. I focus on life science tools and therapeutic platforms. Also: biotechnology, diagnostics, medical devices, quantum computing, materials, semiconductors, nanotechnology, autonomous systems, additive manufacturing, robotics.
Board Member
2021
Board Member
2021
Board Observer
2019
Business development for company creation; led Series A financing.
Board Observer
2019
Business development for company creation; led Series A financing.
Board Observer
2022
Board Observer
2018 - 2021
NASDAQ: MASS
George Schultz Innovation Fund Associate
2017 - 2017
The Innovation Fund invests in science-based startups emanating from U-Chicago and Argonne National Lab. I led seed investments in two pre-clinical therapeutics startups.
Business Development
2017 - 2017
Startup commercializing novel water de-ionization materials technology developed at Argonne National Lab for use in water cooling towers. We competed in Chicago-Booth's New Venture Challenge
Associate
2016 - 2017
Led screening and diligence for healthcare tech investments.